21 results on '"Gorbatyuk, Oleg S."'
Search Results
2. Biodistribution of adeno-associated virus type 2 with mutations in the capsid that contribute to heparan sulfate proteoglycan binding
- Author
-
Gorbatyuk, Oleg S., Warrington, Kenneth H., JR., Gorbatyuk, Marina S., Zolotukhin, Irene, Lewin, Alfred S., and Muzyczka, Nicholas
- Published
- 2019
- Full Text
- View/download PDF
3. Tribbles homolog 3-mediated targeting the AKT/mTOR axis in mice with retinal degeneration
- Author
-
Saltykova, Irina V., Elahi, Asif, Pitale, Priyam M., Gorbatyuk, Oleg S., Athar, Mohammad, and Gorbatyuk, Marina S.
- Published
- 2021
- Full Text
- View/download PDF
4. Retinoid X Receptor Activation Prevents Diabetic Retinopathy in Murine Models.
- Author
-
Dorofeeva, Iuliia, Zhylkibayev, Assylbek, Saltykova, Irina V., Atigadda, Venkatram, Adhikari, Bibek, Gorbatyuk, Oleg S., Grant, Maria B., and Gorbatyuk, Marina S.
- Subjects
DIABETIC retinopathy ,HYPERGLYCEMIA ,TYPE 1 diabetes ,GLUCOSE analysis ,TYPE 2 diabetes ,EYE drops ,RETINOID X receptors - Abstract
Previously, the RXR agonist UAB126 demonstrated therapeutic potential to treat obese mice by controlling blood glucose levels (BGL) and altering the expression of genes associated with lipid metabolism and inflammatory response. The purpose of the study was to assess the effects of UAB126 on the progression of diabetic retinopathy (DR) in rodent models of type 1 diabetes (T1D), streptozotocin-induced, and type 2 diabetes (T2D), in db/db mice. UAB126 treatment was delivered either by oral gavage for 6 weeks or by topical application of eye drops for 2 weeks. At the end of the treatment, the retinal function of diabetic mice was assessed by electroretinography (ERG), and their retinal tissue was harvested for protein and gene expression analyses. Bone-marrow cells were isolated and differentiated into bone marrow-derived macrophages (BMDMs). The glycolysis stress test and the 2-DG glucose uptake analysis were performed. Our results demonstrated that in the UAB126-treated diabetic BMDMs, the ECAR rate and the 2-DG uptake were improved as compared to untreated diabetic BMDMs. In UAB126-treated diabetic mice, hyperglycemia was reduced and associated with the preservation of ERG amplitudes and enhanced AMPK activity. Retinas from diabetic mice treated with topical UAB126 demonstrated an increase in Rxr and Ppar and the expression of genes associated with lipid metabolism. Altogether, our data indicate that RXR activation is beneficial to preclinical models of DR. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons
- Author
-
Salganik, Maxim, Sergeyev, Valeriy G., Shinde, Vishal, Meyers, Craig A., Gorbatyuk, Marina S., Lin, Jonathan H., Zolotukhin, Sergey, and Gorbatyuk, Oleg S.
- Published
- 2015
- Full Text
- View/download PDF
6. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78
- Author
-
Gorbatyuk, Marina. S., Knox, Tessa, LaVail, Matthew M., Gorbatyuk, Oleg S., Noorwez, Syed M., Hauswirth, William W., Lin, Jonathan H., Muzyczka, Nicholas, Lewin, Alfred S., and Berns, Kenneth I.
- Published
- 2010
7. The Phosphorylation State of Ser-129 in Human α-Synuclein Determines Neurodegeneration in a Rat Model of Parkinson Disease
- Author
-
Gorbatyuk, Oleg S., Li, Shoudong, Sullivan, Layla F., Chen, Weijun, Kondrikova, Galina, Manfredsson, Fredric P., Mandel, Ronald J., and Muzyczka, Nicholas
- Published
- 2008
- Full Text
- View/download PDF
8. GADD34 Ablation Exacerbates Retinal Degeneration in P23H RHO Mice.
- Author
-
Saltykova, Irina V., Zhylkibayev, Assylbek, Gorbatyuk, Oleg S., and Gorbatyuk, Marina S.
- Subjects
RETINAL degeneration ,WESTERN immunoblotting ,PHOSPHOPROTEIN phosphatases ,MICE ,RETINA - Abstract
The UPR is sustainably activated in degenerating retinas, leading to translational inhibition via p-eIF2α. Recent findings have demonstrated that ablation of growth arrest and DNA damage-inducible protein 34 (GADD34), a protein phosphatase 1 regulatory subunit permitting translational machinery operation through p-eIF2α elevation, does not impact the rate of translation in fast-degenerating rd16 mice. The current study aimed to validate whether P23H RHO mice degenerating at a slower pace manifest translational attenuation and whether GADD34 ablation impacts the rate of retinal degeneration via further suppression of retinal protein synthesis and apoptotic cell death. For this study, mice were examined with ERG and histological analyses. The molecular assessment was conducted in the naïve and LPS-challenged mice using Western blot and qRT-PCR analyses. Thus, this study demonstrates that the P23H RHO retinas manifest translational attenuation. However, GADD34 ablation resulted in a more prominent p-eIF2a increase without impacting the translation rate. GADD34 deficiency also led to a reduction in scotopic ERG amplitudes and an increased number of TUNEL-positive cells. Molecular analysis revealed that GADD34 deficiency reduces the expression of p-STAT3 and Il-6 while increasing the expression of Tnfa. Overall, the data indicate that GADD34 plays a multifunctional role. Under chronic UPR activation, GADD34 acts as a feedback player, dephosphorylating p-eIF2a, although this role does not seem to be critical. Additionally, GADD34 controls cytokine expression and STAT3 activation. Perhaps these molecular events are particularly important in controlling the pace of retinal degeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. The phosphorylation state of Ser-129 in human [alpha]-synuclein determines neurodegeneration in a rat model of Parkinson disease
- Author
-
Gorbatyuk, Oleg S., Li, Shoudong, Sullivan, Layla F., Chen, Weijun, Kondrikova, Galina, Manfredsson, Fredric P., Mandel, Ronald J., and Muzyczka, Nicholas
- Subjects
Parkinson's disease -- Models ,Parkinson's disease -- Physiological aspects ,Parkinson's disease -- Drug therapy ,Phosphorylation -- Influence ,Dopamine -- Properties ,Dopamine -- Influence ,Tyrosine -- Properties ,Tyrosine -- Influence ,Science and technology - Abstract
Studies have shown that [alpha]-synuclein ([alpha]-syn) deposited in Lewy bodies in brain tissue from patients with Parkinson disease (PD) is extensively phosphorylated at Ser-129. We used recombinant Adeno-associated virus (rAAV) to overexpress human wild-type (wt) [alpha]-syn and two human [alpha]-syn mutants with site-directed replacement of Ser-129 to alanine ($129A) or to aspartate ($129D) in the nigrostriatal tract of the rat to investigate the effect of Ser-129 phosphorylation state on dopaminergic neuron pathology. Rats were injected with rAAV2/5 vectors in the substantia nigra pars compacta (SNc) on one side of the brain; the other side remained as a nontransduced control. The level of human wt or mutant [alpha]-syn expressed on the injected side was about four times the endogenous rat [alpha]-syn. There was a significant reduction of dopaminergic neurons in the SNc and dopamine (DA) and tyrosine hydroxylase (TH) levels in the striatum of all S129A-treated rats as early as 4 wk postinjection. Nigral DA pathology occurred more slowly in the wt-injected animals, but by 26 wk the wt [alpha]-syn group lost nigral TH neurons equivalent to the mutated S129A group at 8 wk. In stark contrast, we did not observe any pathological changes in S129D-treated animals. Therefore, the nonphosphorylated form of $129 exacerbates [alpha]-syn-induced nigral pathology, whereas Ser-129 phosphorylation eliminates [alpha]-syn-induced nigrostriatal degeneration. This suggests possible new therapeutic targets for Parkinson Disease. AAV | dopamine | Lewy body | tyrosine hydroxylase
- Published
- 2008
10. A Novel Tree Shrew Model of Diabetic Retinopathy.
- Author
-
Gorbatyuk, Oleg S., Pitale, Priyamvada M., Saltykova, Irina V., Dorofeeva, Iuliia B., Zhylkibayev, Assylbek A., Athar, Mohammad, Fuchs, Preston A., Samuels, Brian C., and Gorbatyuk, Marina S.
- Subjects
DIABETIC retinopathy ,RETINAL ganglion cells ,SHREWS ,INSULIN resistance ,IMMUNOHISTOCHEMISTRY - Abstract
Existing animal models with rod-dominant retinas have shown that hyperglycemia injures neurons, but it is not yet clearly understood how blue cone photoreceptors and retinal ganglion cells (RGCs) deteriorate in patients because of compromised insulin tolerance. In contrast, northern tree shrews (Tupaia Belangeri), one of the closest living relatives of primates, have a cone-dominant retina with short wave sensitivity (SWS) and long wave sensitivity (LWS) cones. Therefore, we injected animals with a single streptozotocin dose (175 mg/kg i.p.) to investigate whether sustained hyperglycemia models the features of human diabetic retinopathy (DR). We used the photopic electroretinogram (ERG) to measure the amplitudes of A and B waves and the photopic negative responses (PhNR) to evaluate cone and RGC function. Retinal flat mounts were prepared for immunohistochemical analysis to count the numbers of neurons with antibodies against cone opsins and RGC specific BRN3a proteins. The levels of the proteins TRIB3, ISR-1, and p-AKT/p-mTOR were measured with western blot. The results demonstrated that tree shrews manifested sustained hyperglycemia leading to a slight but significant loss of SWS cones (12%) and RGCs (20%) 16 weeks after streptozotocin injection. The loss of BRN3a-positive RGCs was also reflected by a 30% decline in BRN3a protein expression. These were accompanied by reduced ERG amplitudes and PhNRs. Importantly, the diabetic retinas demonstrated increased expression of TRIB3 and level of p-AKT/p-mTOR axis but reduced level of IRS-1 protein. Therefore, a new non-primate model of DR with SWS cone and RGC dysfunction lays the foundation to better understand retinal pathophysiology at the molecular level and opens an avenue for improving the research on the treatment of human eye diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Molecular Mechanism of the Constitutive Activation of the L250Q Human Melanocortin-4 Receptor Polymorphism
- Author
-
Proneth, Bettina, Xiang, Zhimin, Pogozheva, Irina D., Litherland, Sally A., Gorbatyuk, Oleg S., Shaw, Amanda M., Millard, William J., Mosberg, Henry I., and Haskell-Luevano, Carrie
- Published
- 2006
12. Salivary Peptide Tyrosine-Tyrosine 3-36 Modulates Ingestive Behavior without Inducing Taste Aversion.
- Author
-
Hurtado, Maria D., Sergeyev, Valeriy G., Acosta, Andres, Spegele, Michael, La Sala, Michael, Waler, Nickolas J., Chiriboga-Hurtado, Juan, Currlin, Seth W., Herzog, Herbert, Dotson, Cedrick D., Gorbatyuk, Oleg S., and Zolotukhin, Sergei
- Subjects
TASTE aversion ,PEPTIDE YY ,INGESTION ,SALIVARY gland physiology ,ENDOCRINE system ,BRAIN stem physiology - Abstract
Hormone peptide tyrosine-tyrosine (PYY) is secreted into circulation from the gut L-endocrine cells in response to food intake, thus inducing satiation during interaction with its preferred receptor, Y
2 R. Clinical applications of systemically administered PYY for the purpose of reducing body weight were compromised as a result of the common side effect of visceral sickness. We describe here a novel approach of elevating PYY in saliva in mice, which, although reliably inducing strong anorexic responses, does not cause aversive reactions. The augmentation of salivary PYY activated forebrain areas known to mediate feeding, hunger, and satiation while minimally affecting brainstem chemoreceptor zones triggering nausea. By comparing neuronal pathways activated by systemic versus salivary PYY, we identified a metabolic circuit associated with Y2 R-positive cells in the oral cavity and extending through brainstem nuclei into hypothalamic satiety centers. The discovery of this alternative circuit that regulates ingestive behavior without inducing taste aversion may open the possibility of a therapeutic application of PYY for the treatment of obesity via direct oral application. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
13. α-Synuclein Expression in Rat Substantia Nigra Suppresses Phospholipase D2 Toxicity and Nigral Neurodegeneration.
- Author
-
Gorbatyuk, Oleg S., Shoudong Li, Nha Nguyen, Frederic, Manfredsson, Fredric P., Kondrikova, Galina, Sullivan, Layla F., Meyers, Craig, Weijun Chen, Mandel, Ronald J., and Muzyczka, Nicholas
- Subjects
- *
GENETIC transformation , *PARKINSON'S disease , *IN vivo toxicity testing , *SMALL interfering RNA , *ENZYMES , *AMINO acids , *GENE amplification , *DOPAMINE - Abstract
We present genetic evidence that an in vivo role of α-synuclein (α-syn) is to inhibit phospholipase D2 (PLD2), an enzyme that is believed to participate in vesicle trafficking, membrane signaling, and both endo- and exocytosis. Overexpression of PLD2 in rat substantia nigra pars compacta (SNc) caused severe neurodegeneration of dopamine (DA) neurons, loss of striatal DA, and an associated ipsilateral amphetamine-induced rotational asymmetry. Coexpression of human wild type α-syn suppressed PLD2 neurodegeneration, DA loss, and amphetamine-induced rotational asymmetry. However, an α-syn mutant defective for inhibition of PLD2 in vitro also failed to inhibit PLD toxicity in vivo. Further, reduction of PLD2 activity in SNc, either by siRNA knockdown of PLD2 or overexpression of α-syn, both produced an unusual contralateral amphetamine-induced rotational asymmetry, opposite to that seen with overexpression of PLD2, suggesting that PLD2 and α-syn were both involved in DA release or reuptake. Finally, α-syn coimmunoprecipitated with PLD2 from extracts prepared from striatal tissues. Taken together, our data demonstrate that α-syn is an inhibitor of PLD2 in vivo, and confirm earlier reports that α-syn inhibits PLD2 in vitro. Our data also demonstrate that it is possible to use viral-mediated gene transfer to study gene interactions in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
14. In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal Degeneration.
- Author
-
Gorbatyuk, Oleg S., Shoudong Li, Nash, Kevin, Gorbatyuk, Marina, Lewin, Alfred S., Sullivan, Layla F., Mandel, Ronald J., Weijun Chen, Meyers, Craig, Manfredsson, Fredric P., and Muzyczka, Nicholas
- Subjects
- *
DEGENERATION (Pathology) , *SMALL interfering RNA , *TYROSINE , *DOPAMINE , *AMPHETAMINES , *CELL physiology - Abstract
Two small-interfering RNAs (siRNAs) targeting α-synuclein (α-syn) and three control siRNAs were cloned in an adeno-associated virus (AAV) vector and unilaterally injected into rat substantia nigra pars compacta (SNc). Reduction of α-syn resulted in a rapid (4 week) reduction in the number of tyrosine hydroxylase (TH) positive cells and striatal dopamine (DA) on the injected side. The level of neurodegeneration induced by the different siRNAs correlated with their ability to downregulate α-syn protein and mRNA in tissue culture and in vivo. Examination of various SNc neuronal markers indicated that neurodegeneration was due to cell loss and not just downregulation of DA synthesis. Reduction of α-syn also resulted in a pronounced amphetamine induced behavioral asymmetry consistent with the level of neurodegeneration. In contrast, none of the three control siRNAs, which targeted genes not normally expressed in SNc, showed evidence of neurodegeneration or behavioral asymmetry, even at longer survival times. Moreover, co-expression of both rat α-syn and α-syn siRNA partially reversed the neurodegenerative and behavioral effects of α-syn siRNA alone. Our data show that α-syn plays an important role in the rat SNc and suggest that both up- and downregulation of wild-type α-syn expression increase the risk of nigrostriatal pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
15. Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System
- Author
-
Burger, Corinna, Gorbatyuk, Oleg S., Velardo, Margaret J., Peden, Carmen S., Williams, Philip, Zolotukhin, Sergei, Reier, Paul J., Mandel, Ronald J., and Muzyczka, Nicholas
- Subjects
- *
GENES , *MOLECULAR genetics , *SPINAL cord , *STEREOLOGY - Abstract
Recombinant adeno-associated virus 2 (rAAV2) has been shown to deliver genes to neurons effectively in the brain, retina, and spinal cord. The characterization of new AAV serotypes has revealed that they have different patterns of transduction in diverse tissues. We have investigated the tropism and transduction frequency in the central nervous system (CNS) of three different rAAV vector serotypes. The vectors contained AAV2 terminal repeats flanking a green fluorescent protein expression cassette under the control of the synthetic CBA promoter, in AAV1, AAV2, or AAV5 capsids, producing the pseudotypes rAAV2/1, rAAV2/2, and rAAV2/5. Rats were injected with rAAV2/1, rAAV2/2, or rAAV2/5 into selected regions of the CNS, including the hippocampus (HPC), substantia nigra (SN), striatum, globus pallidus, and spinal cord. In all regions injected, the three vectors transduced neurons almost exclusively. All three vectors transduced the SN pars compacta with high efficiency, but rAAV2/1 and rAAV2/5 also transduced the pars reticulata. Moreover, rAAV2/1 showed widespread distribution throughout the entire midbrain. In the HPC, rAAV2/1 and rAAV2/5 targeted the pyramidal cell layers in the CA1–CA3 regions, whereas AAV2/2 primarily transduced the hilar region of the dentate gyrus. In general, rAAV2/1 and rAAV2/5 exhibited higher transduction frequencies than rAAV2/2 in all regions injected, although the differences were marginal in some regions. Retrograde transport of rAAV1 and rAAV5 was also observed in particular CNS areas. These results suggest that vectors based on distinct AAV serotypes can be chosen for specific applications in the nervous system. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
16. Adeno-Associated Virus Type 2 VP2 Capsid Protein Is Nonessential and Can Tolerate Large Peptide Insertions at Its N Terminus.
- Author
-
Warrington Jr., Kenneth H., Gorbatyuk, Oleg S., Harrison, Jeffrey K., Opie, Shaun R., Zolotukhin, Sergei, and Muzyczka, Nicholas
- Subjects
- *
PEPTIDES , *ADENOVIRUSES , *GREEN fluorescent protein , *PROTEIN analysis , *AMINO acids , *GENETIC engineering , *EPITOPES , *LEPTIN , *CONFOCAL microscopy - Abstract
Direct insertion of amino acid sequences into the adeno-associated virus type 2 (AAV) capsid open reading frame (cap ORF) is one strategy currently being developed for retargeting this prototypical gene therapy vector. While this approach has successfully resulted in the formation of AAV particles that have expanded or retargeted viral tropism, the inserted sequences have been relatively short, linear receptor binding ligands. Since many receptor-ligand interactions involve nonlinear, conformation-dependent binding domains, we investigated the insertion of full-length peptides into the AAV cap ORF. To minimize disruption of critical VP3 structural domains, we confined the insertions to residue 138 within the VP1-VP2 overlap, which has been shown to be on the surface of the particle following insertion of smaller epitopes. The insertion of coding sequences for the 8-kDa chemokine binding domain of rat fractalkine (CX3CL1), the 18-kDa human hormone leptin, and the 30-kDa green fluorescent protein (GFP) after residue 138 failed to lead to formation of particles due to the loss of VP3 expression. To test the ability to complement these insertions with the missing capsid proteins in trans, we designed a system for producing AAV vectors in which expression of one capsid protein is isolated and combined with the remaining two capsid proteins expressed separately. Such an approach allows for genetic modification of a specific capsid protein across its entire coding sequence leaving the remaining capsid proteins unaffected. An examination of particle formation from the individual components of the system revealed that genome-containing particles formed as long as the VP3 capsid protein was present and demonstrated that the VP2 capsid protein is nonessential for viral infectivity. Viable particles composed of all three capsid proteins were obtained from the capsid complementation groups regardless of which capsid proteins were supplied separately in trans. Significant overexpression of VP2 resulted in the formation of particles with altered capsid protein stoichiometry. The key finding was that by using this system we successfully obtained nearly wild-type levels of recombinant AAV-like particles with large ligands inserted after residue 138 in VP1 and VP2 or in VP2 exclusively. While insertions at residue 138 in VP1 significantly decreased infectivity, insertions at residue 138 that were exclusively in VP2 had a minimal effect on viral assembly or infectivity. Finally, insertion of GFP into VP1 and VP2 resulted in a particle whose trafficking could be temporally monitored by using confocal microscopy. Thus, we have demonstrated a method that can be used to insert large (up to 30-kDa) peptide ligands into the AAV particle. This system allows greater flexibility than current approaches in genetically manipulating the composition of the AAV particle and, in particular, may allow vector retargeting to alternative receptors requiring interaction with full-length conformation-dependent peptide ligands. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
17. Evidence for endogenous agmatine in hypothalamo-neurohypophysial tract and its modulation on vasopressin release and Ca2+ channels
- Author
-
Wang, Gang, Gorbatyuk, Oleg S., Dayanithi, Govindan, Ouyang, Wei, Wang, Jialing, Milner, Teresa A., Regunathan, Soundar, and Reis, Donald J.
- Subjects
- *
ARGININE , *HYPOTHALAMUS - Abstract
Agmatine, decarboxylated from arginine by arginine decarboxylase, is particularly prominent in the hypothalamus. The present study utilized the rat hypothalamo-neurohypophysial system to determine expression and ‘pre-synaptic’ modulation of agmatine in the central nervous system (CNS). Under confocal-laser scanning, agmatine-like immunoreactivity (Agm-LI) was found enriched in arginine–vasopressin (AVP)-containing magnocellular neurons of the supraoptic nuclei (SON) and paraventricular nuclei (PVN). In addition, using electron microscopy, Agm-LI was found closely associated with large neurosecretory-like vesicles in neurohypophysial nerve terminals of posterior pituitary gland. Radioimmunoassay revealed that 10 and 30 μM agmatine concentration-dependently inhibited the depolarization-evoked AVP release from isolated neurohypophysial terminals. Using perforated patch-clamp, effects of agmatine on whole-terminal voltage-gated ion currents in the isolated neurohypophysial nerve terminals were examined. While it did not significantly affect either tetrodotoxin (TTX)-sensitive Na+ or sustained Ca2+-activated K+ channel currents, agmatine (1–40 μM) inhibited Ca2+ channel currents in approximately 53% of the total nerve terminals investigated. The onset of inhibitory effect was immediate, and the inhibition was reversible and concentration-dependent with an IC50=4.6 μM. In the remaining (approximately 47%) neurohypophysial nerve terminals, only a higher (120 μM) concentration of agmatine could moderately inhibit Ca2+ channel currents. The results suggest that: (1) endogenous agmatine is co-expressed in AVP-containing, hypothalamic magnocellular neurons of the SON/PVN and in neurohypophysial nerve terminals of posterior pituitary gland; (2) agmatine may serve as a physiological neuromodulator by regulating the voltage-gated Ca2+ channel and, as a result, the release of AVP from neurohypophysial nerve terminals. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
18. The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson’s Disease.
- Author
-
Mendez-Gomez, Hector R., Singh, Jasbir, Meyers, Craig, Chen, Weijun, Gorbatyuk, Oleg S., and Muzyczka, Nicholas
- Subjects
- *
PHOSPHOLIPASE D , *NEURODEGENERATION , *PARKINSON'S disease , *DOPAMINERGIC neurons , *LYSOPHOSPHOLIPIDS - Abstract
Phospholipase D2 (PLD2), an enzyme involved in vesicle trafficking and membrane signaling, interacts with α-synuclein, a protein known to contribute in the development of Parkinson disease (PD). We previously reported that PLD2 overexpression in rat substantia nigra pars compacta (SNc) causes a rapid neurodegeneration of dopamine neurons, and that α-synuclein suppresses PLD2-induced nigral degeneration (Gorbatyuk et al., 2010). Here, we report that PLD2 toxicity is due to its lipase activity. Overexpression of a catalytically inactive mutant (K758R) of PLD2 prevents the loss of dopaminergic neurons in the SNc and does not show signs of toxicity after 10 weeks of overexpression. Further, mutant K758R does not affect dopamine levels in the striatum. In contrast, mutants that prevent PLD2 interaction with dynamin or growth factor receptor bound protein 2 (Grb2) but retained lipase activity, continued to show rapid neurodegeneration. These findings suggest that neither the interaction of PLD2 with dynamin, which has a role in vesicle trafficking, nor the PLD2 interaction with Grb2, which has multiple roles in cell cycle control, chemotaxis and activation of tyrosine kinase complexes, are the primary cause of neurodegeneration. Instead, the synthesis of phosphatidic acid (the product of PLD2), which is a second messenger in multiple cellular pathways, appears to be the key to PLD2 induced neurodegeneration. The fact that α-synuclein is a regulator of PLD2 activity suggests that regulation of PLD2 activity could be important in the progression of PD. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson’s disease.
- Author
-
Gully, Joseph C., Sergeyev, Valeriy G., Bhootada, Yogesh, Mendez-Gomez, Hector, Meyers, Craig A., Zolotukhin, Sergey, Gorbatyuk, Marina S., and Gorbatyuk, Oleg S.
- Subjects
- *
TRANSCRIPTION factors , *DOPAMINE , *NEURONS , *PARKINSON'S disease , *APOPTOSIS - Abstract
Activating transcription factor 4 (ATF4) is a member of the PERK signaling pathway, which directly binds endoplasmic reticulum stress target genes and plays a crucial role in both adaptations to stress and activation of apoptosis. Previous publications demonstrated conflicting evidence on the role of ATF4 in the pathogenesis of neurodegenerative disorders. In this study, we used recombinant adeno-associate virus (rAAV)-mediated gene transfer to investigate if the sustained up-regulation of ATF4 launches a pro-survival or pro-death trend in the dopamine (DA) cells of the substantia nigra pars compacta in a rat model of Parkinson-like neurodegeneration induced by human alpha-synuclein (αS) overexpression. We showed that ATF4 does not protect nigral DA neurons against an αS-induced pathology. Moreover, the rAAV-mediated overexpression of ATF4 resulted in severe nigra-striatal degeneration via activation of caspases 3/7. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
20. Glucose Regulated Protein 78 Diminishes α-Synuclein Neurotoxicity in a Rat Model of Parkinson Disease.
- Author
-
Gorbatyuk, Marina S, Shabashvili, Arseniy, Chen, Weijun, Meyers, Craig, Sullivan, Layla F, Salganik, Max, Lin, Jonathan H, Lewin, Alfred S, Muzyczka, Nicholas, and Gorbatyuk, Oleg S
- Subjects
- *
SYNUCLEINS , *NEUROTOXICOLOGY , *ANIMAL models in research , *PARKINSON'S disease , *CARRIER proteins , *APOPTOSIS , *TYROSINE hydroxylase , *NEUROPROTECTIVE agents - Abstract
Accumulation of human wild-type (wt) α-synuclein (α-syn) induces neurodegeneration in humans and in experimental rodent models of Parkinson disease (PD). It also leads to endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR). We overexpressed glucose regulated protein 78, also known as BiP (GRP78/BiP), to test the hypothesis that this ER chaperone modulates the UPR, blocks apoptosis, and promotes the survival of nigral dopamine (DA) neurons in a rat model of PD induced by elevated level of human α-syn. We determined that α-syn activates ER stress mediators associated with pancreatic ER kinase-like ER kinase (PERK) and activating transcription factor-6 (ATF6) signaling pathways as well as proaoptotic CCAAT/-enhancer-binding protein homologous protein (CHOP) in nigral DA neurons. At the same time, overexpression of GRP78/BiP diminished α-syn neurotoxicity by down regulating ER stress mediators and the level of apoptosis, promoted survival of nigral tyrosine hydroxylase (TH) positive cells and resulted in higher levels of striatal DA, while eliminating amphetamine induced behavioral asymmetry. We also detected a complex between GRP78/BiP and α-syn that may contribute to prevention of the neurotoxicity caused by α-syn. Our data suggest that the molecular chaperone GRP78/BiP plays a neuroprotective role in α-syn-induced Parkinson-like neurodegeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
21. Nigrostriatal rAAV-mediated GDNF Overexpression Induces Robust Weight Loss in a Rat Model of Age-related Obesity.
- Author
-
Manfredsson, Fredric P., Tumer, Nihal, Erdos, Benedek, Landa, Tessa, Broxson, Christopher S., Sullivan, Layla F., Rising, Aaron C., Foust, Kevin D., Yi Zhang, Muzyczka, Nicholas, Gorbatyuk, Oleg S., Scarpace, Philip J., and Mandel, Ronald J.
- Subjects
- *
WEIGHT loss , *LABORATORY rats , *CELL lines , *PARKINSON'S disease , *HYPOTHALAMUS physiology , *SUBSTANTIA nigra , *NUCLEUS accumbens , *ADRENOCORTICOTROPIC hormone - Abstract
Intraventricular administration of glial cell line–derived neurotrophic factor (GDNF) in primate and humans to study Parkinson's disease (PD) has revealed the potential for GDNF to induce weight loss. Our previous data indicate that bilateral continuous hypothalamic GDNF overexpression via recombinant adeno-associated virus (rAAV) results in significant failure to gain weight in young rats and weight loss in aged rats. Based on these previous results, we hypothesized that because the nigrostriatal tract passes through the lateral hypothalamus, motor hyperactivity mediated by nigrostriatal dopamine (DA) may have been responsible for the previously observed effect on body weight. In this study, we compared bilateral injections of rAAV2/5-GDNF in hypothalamus versus substantia nigra (SN) in aged Brown-Norway X Fisher 344 rats. Nigrostriatal GDNF overexpression resulted in significantly greater weight loss than rats treated in hypothalamus. The nigral or hypothalamic GDNF-induced weight loss was unrelated to motor activity levels of the rats, though some of the weight loss could be attributed to a transient reduction in food intake. Forebrain DA levels did not account for the observed effects on body weight, although GDNF-induced increases in nucleus accumbens DA may have partially contributed to this effect in the hypothalamic GDNF-treated group. However, only nigrostriatal GDNF overexpression induced activation of phosphorylated extracellular signal-regulated kinase (p-ERK) in a small population of corticotrophin-releasing factor [corticotrophin-releasing hormone (CRH)] neurons located specifically in the medial parvocellullar division (MPD) of the paraventricular nucleus of the hypothalamus. Activation of these hypothalamic CRH neurons likely accounted for the observed metabolic effects leading to weight loss in obese rats.Molecular Therapy (2009) 17 6, 980–991 doi:10.1038/mt.2009.45 [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.